- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PIK3CA mutated
Total 561 results
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, Turkey, India, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, Italy, United Kingdom, Poland, Taiwan, Colombia, France, Germany, Mexico
-
Hoffmann-La RocheRecruitingBreast CancerCanada, Belgium, Korea, Republic of, United States, China, Taiwan, Mexico, Brazil, Argentina, Australia, Italy, Spain, Turkey, Thailand, United Kingdom, Poland, South Africa
-
UNICANCERNovartis; Breast Cancer Research FoundationRecruiting
-
GOG FoundationNovartisRecruitingEndometroid Endometrial CancerUnited States
-
Menarini GroupCompletedMetastatic Colorectal CancerSpain, Italy, Netherlands, Germany, United States, France, Poland
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Memorial Sloan Kettering Cancer CenterKazia TherapeuticsActive, not recruitingBrain Metastases | Leptomeningeal MetastasisUnited States
-
Spanish Breast Cancer Research GroupNovartis Pharmaceuticals; ETOP IBCSG Partners Foundation; Breast International...Active, not recruitingAdvanced Breast CancerSpain, Netherlands, France, Italy, Austria, Switzerland
-
AstraZenecaCompletedAdvanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast CancerCanada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria
-
UNICANCERTerminated
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCTerminatedRectal Cancer | Colon CancerUnited States
-
Shanghai Chest HospitalRecruitingNon Small Cell Lung CancerChina
-
Shanghai Pharmaceuticals Holding Co., LtdNot yet recruitingBiliary Tract or Colorectal Cancer With Her2-positive/MutatedChina
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingOvarian CancerUnited States, Germany
-
National Cancer Centre, SingaporeRecruitingAdvanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung CancerKorea, Republic of, Taiwan, Singapore
-
AstraZenecaDaiichi SankyoNot yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEndometrial Carcinoma | Recurrent or Metastatic | TP53 MutationChina
-
HutchmedRecruitingAcute Myeloid LeukemiaChina
-
The First Affiliated Hospital of Guangzhou Medical...RecruitingCarcinoma, Squamous Cell | Lung CancerChina
-
Eilean TherapeuticsNot yet recruiting
-
Guangzhou Institute of Respiratory DiseaseRecruiting
-
Avistone Biotechnology Co., Ltd.RecruitingNon-Small-Cell Lung CancerChina
-
Guangzhou Institute of Respiratory DiseaseRecruiting
-
National Cancer Institute (NCI)Not yet recruiting
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Recruiting
-
Medical College of WisconsinNot yet recruitingNon Small Cell Lung CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Zhejiang UniversityNot yet recruitingEGF-R Positive Non-Small Cell Lung Cancer
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
Ryan Gentzler, MDMirati Therapeutics Inc.; University of VirginiaRecruitingAdagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain MetastasesNSCLC | Non Small Cell Lung Cancer | KRAS G12CUnited States
-
Frontier Medicines CorporationRecruitingColorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Unresectable Solid Tumor | KRAS G12C | Advanced Solid Tumors With KRAS G12C MutationsUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsChina
-
M.D. Anderson Cancer CenterGlaxoSmithKlineRecruiting
-
Uma BorateRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Acute Myeloid Leukemia With KMT2A Rearrangement | Acute Myeloid Leukemia With NPM1 MutationUnited States
-
Fudan UniversityRecruitingMetastatic Colorectal Cancer | Microsatellite Stable Colorectal Carcinoma | RAS Mutation | CadonilimabChina
-
Megan Kruse, MDAnHeart Therapeutics Inc.Not yet recruitingBreast Cancer | Metastatic Breast CancerUnited States
-
Spanish Cooperative Group for the Treatment of...Merck, S.L., Spain; Pierre Fabre Ibérica, S.A.Not yet recruiting
-
Erasmus Medical CenterUniversitaire Ziekenhuizen KU Leuven; University Medical Center Groningen; Academisch... and other collaboratorsNot yet recruitingGlioma | Radiotherapy; Complications
-
National Cancer Institute (NCI)RecruitingLocally Advanced Chondrosarcoma | Metastatic Chondrosarcoma | Metastatic Sinonasal Adenocarcinoma | Locally Advanced Sinonasal Adenocarcinoma | Metastatic Large-cell Neuroendocrine Carcinoma | Locally Advanced Large-cell Neuroendocrine Carcinoma | Metastatic Olfactory Neuroblastoma | Locally Advanced... and other conditionsUnited States
-
Pamela MunsterNational Cancer Institute (NCI)RecruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene Mutation | BRCA Mutation | Checkpoint Kinase 2 Gene MutationUnited States
-
Revolution Medicines, Inc.RecruitingNon-Small Cell Lung Cancer, NSCLC | KRAS, NRAS, HRAS-mutated NSCLC | KRAS G12C-mutated Solid Tumors, Lung Cancer | Lung Cancer Stage IV, Advanced Solid Tumor, CancerUnited States
-
The First Affiliated Hospital of Xiamen UniversityShanxi Province Cancer Hospital; Sun Yat-sen University; Jiangsu Provincial People... and other collaboratorsRecruiting
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2 Expressing or Mutated Advanced Malignant Solid TumorsChina
-
Janssen Research & Development, LLCRecruitingNeoplasms | Myeloproliferative Disorders | Essential Thrombocythemia | MyelofibrosisUnited States, Spain, France, Canada
-
M.D. Anderson Cancer CenterMirati Therapeutics Inc.RecruitingAdvanced Solid Tumor | Non-small Cell Lung CancersUnited States
-
Janssen Research & Development, LLCRecruitingCarcinoma, Non-Small-Cell LungUnited States, Taiwan, Korea, Republic of, Malaysia, Turkey, France, Spain, China, Germany, Argentina
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingNon-small Cell Lung CancerChina